Prescription drug · ANDA
metoprolol succinate NDC 82868-083
Metoprolol succinate 25 mg/1 · Tablet, Extended release · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82868-083-30 | 82868008330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-083-30)Marketed from Jun 25, 2025 | |
| 82868-083-90 | 82868008390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-083-90)Marketed from Jun 25, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- metoprolol succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 25 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203894
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 82868-083_54dab573-f40c-08c7-e063-6294a90a5cacSPL ID 54dab573-f40c-08c7-e063-6294a90a5cacSPL set ID 471bca3e-3401-6814-e063-6394a90a9cb1RxCUI 866427UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482868008330followed by a unit qualifier and the quantityPackage 82868-0083-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Angina Pectoris. (1.2) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure (1.3) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203894
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-567 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3122 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | St. Mary's Medical Park Pharmacy | 60760-663 |
| metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 63629-3286 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-566 |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-564 |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals (USA) Inc. | 68382-565 |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-5418 |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3164 |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-1875 |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-1878 |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Proficient Rx LP | 82804-198 |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1338 |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1339 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1340 |
| metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1341 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-5411 |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3143 |
| Metoprolol Succinate ER | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Direct_Rx | 72189-547 |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-1951 |
Showing 20 of 25.